Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.
- DOI
- 10.1161/strokeaha.125.053168
- Published
- 2026 Jan
- Container
- Stroke
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1161/strokeaha.125.053168,
title = {Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.},
author = {Patel SH and Diaz IC and Zhang Z and Zhao W and Dietrich WD and Bramlett HM and Szczesna-Cordary D and Raval AP},
year = {2026},
journal = {Stroke},
doi = {10.1161/strokeaha.125.053168},
url = {https://doi.org/10.1161/strokeaha.125.053168}
}RIS
TY - JOUR TI - Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats. AU - Patel SH AU - Diaz IC AU - Zhang Z AU - Zhao W AU - Dietrich WD AU - Bramlett HM AU - Szczesna-Cordary D AU - Raval AP PY - 2026 JO - Stroke DO - 10.1161/strokeaha.125.053168 UR - https://doi.org/10.1161/strokeaha.125.053168 ER -
APA
SH, P., IC, D., Z, Z., W, Z., WD, D., HM, B., D, S., & AP, R. (2026). Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.. Stroke. https://doi.org/10.1161/strokeaha.125.053168
Source records
- pubmed · retrieved 2026-09-26T16:24:01.679Z